The nomogram of contrast-enhanced ultrasound-targeted fusion biopsy predicts the pathology upgrade in prostate cancer
The nomogram integrating CEUS-targeted fusion biopsy variables effectively predicted the risk of pathology upgrade in prostate cancer, which showed potential to guide clinicians in optimizing surgical management in patients with prostate cancer.
Authors
- Jun-Biao Zheng (ORCID: https://orcid.org/0000-0002-0228-4946)
- Bin Feng (ORCID: https://orcid.org/0000-0002-0784-8309)
- Jianhui Cao
Institutions
- First People's Hospital of Yuhang District (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-17
- DOI
- https://doi.org/10.3389/fonc.2025.1632501
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00